6 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Erenumab for Episodic Migraine ... Neuro #Erenumab #Migraine ... #CGRP #VisualAbstract ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Group #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... AdverseEvents #NEJM ... #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
antigen-presenting cell, MLC ... Pathophysiology #IM ... Immunosuppression #NEJM
Chest radiography showed perihilar opacities in both lungs with free air in the mediastinum (Panel A,
#Clinical #PCC # ... IM #EM #Pneumomediastinum ... #Influenza #NEJM